<p>(A) Hep G2, SMMC7721 and LO2 cells treated with ARG (0, 1.56, 12.5, 100 μM) for 24 h were double-stained with Annexin V-FITC/PI and analyzed by flow cytometry. Quantification of population rate of early apoptotic cells (Annexin V+/PI− cells, lower right quadrant) and late apoptotic cells (Annexin V+/PI+ cells, upper right quadrants) were shown. Data represent the mean ± SD of triplicate experiments. Significant differences from vehicle-treated control were indicated as *p<0.05, **P<0.01, ***P<0.0001 in each cell line. (B) HepG2 and SMMC7721 cells were treated with ARG at the concentration of 20 μM for 48 h. The nuclei morphology changes were analyzed by Hoechst 33342 staining and the immunofluorescence analysis of cleaved caspase-3 are v...
<p>The proportion of annexin V-positive apoptotic cells(lower right quadrant) was evaluated by flow ...
<p>HepG2-NS5A (<i>A</i>) and HepG2 control (<i>B</i>) cells were treated with 0–10 μM MG132 for 48 h...
(A) Microscopic analysis of live cells following treatment with Slc3a2 siRNA or scrambled control. (...
<p>HepG2 cells were incubated for 72h with EM-d-Rha at 0, 2.5μM, 5μM, 10μM, respectively. And cells ...
<p><b>A.</b> LH86 and <b>B.</b> Huh7 cells were treated with ABT-263 (0–20 µM) for up to 24 h. Apopt...
<p>MIN6 cells were mock-infected or infected with 1.0 MOI of HCV. (<b>A</b>) Confocal image of cells...
<p>(A) The indicated cell lines were treated with MKT-077 (MKT) or 17-AAG alone or in combination at...
<p>(<b>A</b>) Annexin V expression determined by flow cytometry. HLCZ01 and Huh7.5 cells were infect...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>(a) Flow cytometry was performed to detect apoptosis using Annexin V-FITC/PI staining in C-kit<su...
<p><b>A.</b> Representative flow cytometric analyses of apoptosis are shown. Four subpopulations and...
<p>Percentage of apoptotic cells was measured by flow cytometry after annexin-V/propidium iodide (PI...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>HepG2 cells were treated with 0.6 mM H<sub>2</sub>O<sub>2</sub> for 8 h. (A) The percentage of ap...
<p><b>(A)</b> Three different human RCC derived cell lines were seeded on 96-well plates at a concen...
<p>The proportion of annexin V-positive apoptotic cells(lower right quadrant) was evaluated by flow ...
<p>HepG2-NS5A (<i>A</i>) and HepG2 control (<i>B</i>) cells were treated with 0–10 μM MG132 for 48 h...
(A) Microscopic analysis of live cells following treatment with Slc3a2 siRNA or scrambled control. (...
<p>HepG2 cells were incubated for 72h with EM-d-Rha at 0, 2.5μM, 5μM, 10μM, respectively. And cells ...
<p><b>A.</b> LH86 and <b>B.</b> Huh7 cells were treated with ABT-263 (0–20 µM) for up to 24 h. Apopt...
<p>MIN6 cells were mock-infected or infected with 1.0 MOI of HCV. (<b>A</b>) Confocal image of cells...
<p>(A) The indicated cell lines were treated with MKT-077 (MKT) or 17-AAG alone or in combination at...
<p>(<b>A</b>) Annexin V expression determined by flow cytometry. HLCZ01 and Huh7.5 cells were infect...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>(a) Flow cytometry was performed to detect apoptosis using Annexin V-FITC/PI staining in C-kit<su...
<p><b>A.</b> Representative flow cytometric analyses of apoptosis are shown. Four subpopulations and...
<p>Percentage of apoptotic cells was measured by flow cytometry after annexin-V/propidium iodide (PI...
<p>. The fluorescence profile of untreated HeLa cells. Untreated HeLa cells were collected and incub...
<p>HepG2 cells were treated with 0.6 mM H<sub>2</sub>O<sub>2</sub> for 8 h. (A) The percentage of ap...
<p><b>(A)</b> Three different human RCC derived cell lines were seeded on 96-well plates at a concen...
<p>The proportion of annexin V-positive apoptotic cells(lower right quadrant) was evaluated by flow ...
<p>HepG2-NS5A (<i>A</i>) and HepG2 control (<i>B</i>) cells were treated with 0–10 μM MG132 for 48 h...
(A) Microscopic analysis of live cells following treatment with Slc3a2 siRNA or scrambled control. (...